Ignite Creation Date:
2025-12-24 @ 11:19 PM
Ignite Modification Date:
2026-01-01 @ 10:31 PM
Study NCT ID:
NCT03979456
Status:
UNKNOWN
Last Update Posted:
2021-04-19
First Post:
2019-06-03
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
RItuximab Long-Term DOSE Trial in Multiple Sclerosis - RIDOSE-MS
Sponsor:
Karolinska Institutet
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-07-04
Start Date Type:
ACTUAL
Primary Completion Date:
2024-12-20
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-06-01
Completion Date Type:
ESTIMATED
First Submit Date:
2019-06-03
First Submit QC Date:
None
Study First Post Date:
2019-06-07
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-04-15
Last Update Post Date:
2021-04-19
Last Update Post Date Type:
ACTUAL